LPTX News - Candlesense

Leap Therapeutics Reports Second Quarter 2025 Financial Results

CAMBRIDGE, Mass., Aug. 14, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financ...

How does the company's cash‑burn rate compare to previous quarters and to industry peers? Are there upcoming catalyst events (e.g., FDA decisions, conference presentations) that could move the stock? What impact do the recent board changes have on corporate governance and strategy?

Earnings

27 days ago